Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06881108 · ClinicalTrials.gov registry record
Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors
A clinical trial of Malignant Solid Neoplasm and Hematopoietic Neoplasm, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT06881108: Completed study of Malignant Solid Neoplasm and Hematopoietic Neoplasm, sponsored by Wake Forest University Health Sciences.
NCT06881108 is a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 16 participants, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06881108, a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to develop, test, and revise an intervention designed to address financial hardship (FinFit) among adolescent and young adult (AYA) cancer survivors.
Primary Outcome
Through the analysis of secondary outcomes (CHAT Core Functions - Step 1 LIFT Core Functions - Step 2) to develop, test, and revise an intervention designed to address financial hardship among adolescent and young adults using semi-structured interview data and analysis for the creation of protocol intervention including when, how and to whom the intervention should be delivered to.
Conditions Studied
Interventions
- OTHER CHAT Core Functions
- OTHER LIFT Core Functions
- OTHER Member-Checking Process
Study Locations (1)
North Carolina
- Wake Forest Baptist Comprehensive Cancer - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2025-09-05 |
What the finished NCT06881108 record still lists
NCT06881108 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which CHAT Core Functions is the first listed.
NCT06881108 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06881108 about?
NCT06881108 is a clinical study titled "Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors". This study seeks to develop, test, and revise an intervention designed to address financial hardship (FinFit) among adolescent and young adult (AYA) cancer survivors.
What is the current status of trial NCT06881108?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2024-11-04. Estimated completion is 2025-09-05.
What conditions does trial NCT06881108 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic Neoplasm, Lymphatic System Neoplasm.
What interventions are being tested in trial NCT06881108?
The interventions under investigation include: CHAT Core Functions (OTHER), LIFT Core Functions (OTHER), Member-Checking Process (OTHER).
Who is sponsoring clinical trial NCT06881108?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06881108 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06881108's enrollment target sits among peer trials
16 165th of 176 higher than 12 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Voices: Messages of Wisdom and Hope in the Face of Illness
RECRUITING
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI